Targeting oxidative phosphorylation as an approach for the treatment of ovarian cancer
- PMID: 36147929
- PMCID: PMC9486401
- DOI: 10.3389/fonc.2022.971479
Targeting oxidative phosphorylation as an approach for the treatment of ovarian cancer
Abstract
Ovarian cancer is an aggressive tumor that remains to be the most lethal gynecological malignancy in women. Metabolic adaptation is an emerging hallmark of tumors. It is important to exploit metabolic vulnerabilities of tumors as promising strategies to develop more effective anti-tumor regimens. Tumor cells reprogram the metabolic pathways to meet the bioenergetic, biosynthetic, and mitigate oxidative stress required for tumor cell proliferation and survival. Oxidative phosphorylation has been found to be altered in ovarian cancer, and oxidative phosphorylation is proposed as a therapeutic target for management of ovarian cancer. Herein, we initially introduced the overview of oxidative phosphorylation in cancer. Furthermore, we discussed the role of oxidative phosphorylation and chemotherapeutic resistance of ovarian cancer. The role of oxidative phosphorylation in other components of tumor microenvironment of ovarian cancer has also been discussed.
Keywords: metabolic reprograming; mitochondria; ovarian cancer; oxidative phoshorylation; resistance.
Copyright © 2022 Wu, Zhang, Wang, Zheng, Cao and Shen.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Dey P, Kimmelman AC, DePinho RA. Metabolic codependencies in the tumor microenvironment. Cancer Discovery (2021) 11(5):1067–81. doi: 10.1158/2159-8290.CD-20-1211 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
